The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Neuroleptic Malignant Syndrome
Abstract
NEUROLEPTIC drugs, also known as antipsychotic agents and "major" tranquilizers, are among the most commonly prescribed medications in use today. In 1983 six neuroleptic agents were among the 200 most prescribed drugs in the United States.1 Neuroleptic drugs are used extensively in the treatment of psychotic illnesses and are widely employed in general medicine as antiemetics, for dissociative anesthesia, and to treat diseases such as Tourette's syndrome. They have many well-known side effects —e.g., extrapyramidal effects.2 The neuroleptic malignant syndrome (NMS), however, a hyperpyrexic syndrome that is frequently fatal, is not widely recognized. In fact, one popular, authoritative textbook makes . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroleptic malignant syndrome: A pathogenetic role for dopamine receptor blockade?
Henderson, V. W., & Wooten, G. F. (1981) · Neurology · doi:10.1212/wnl.31.2.132 · Cited by 339
Neuroleptic Malignant Syndrome-like State Following a Withdrawal of Antiparkinsonian Drugs
TORU, M., MATSUDA, O., MAKIGUCHI, K., & SUGANO, K. (1981) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198105000-00011 · Cited by 213
Burke, R. E., Fahn, S., Mayeux, R., Weinberg, H., Louis, K., & Willner, J. H. (1981) · Neurology · doi:10.1212/wnl.31.8.1022 · Cited by 171
Amantadine-Dopamine Interaction: Possible Mode of Action in Parkinsonism
Grelak, R. P., Clark, R., Stump, J. M., & Vernier, V. G. (1970) · Science · doi:10.1126/science.169.3941.203 · Cited by 166
Neuroleptic Malignant Syndrome: Successful Treatment With Bromocriptine
Mueller, P. S. (1983) · JAMA · doi:10.1001/jama.249.3.386 · Cited by 154
Neuroleptic malignant syndrome: Successful treatment with dantrolene and bromocriptine
Granato, J. E., Stern, B. J., Ringel, A., Karim, A. H., Krumholz, A., Coyle, J. T., & Adler, S. (1983) · Annals of Neurology · doi:10.1002/ana.410140117 · Cited by 135
MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS.
Goldberg, L. I. (1964) · PubMed · Cited by 124
Goldberg, L. I. (1964) · JAMA · doi:10.1001/jama.1964.03070180054008 · Cited by 117
Fatal hyperpyrexia after withdrawal of levodopa
Sechi, G., Tanda, F., & Mutani, R. (1984) · Neurology · doi:10.1212/wnl.34.2.249 · Cited by 102
Neuroleptic Malignant Syndrome: Response to Dantrolene Sodium
MAY, D. C., Morris, S. W., STEWART, R. M., FENTON, B. J., & GAFFNEY, F. A. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-2-183 · Cited by 91
Cited by
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
A Hyperthermic Syndrome in Two Subjects With Acute Hydrocephalus
Talman, W. T., Florek, G., & Bullard, D. E. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520330129022 · Cited by 38
Metadata
- Authors
- Guzé, B. H., & Baxter, L. R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1985-07-18
- Volume
- 313
- Issue
- 3
- Pages
- 163-166
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3170316809
- Cited by
- 312
- References
- 11
- FWCI
- 22.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroleptic Malignant Syndrome. https://app.cochat.ai/papers/10.1056/nejm198507183130306
- The paper
- Guzé, B. H., & Baxter, L. R. (1985). Neuroleptic Malignant Syndrome. New England Journal of Medicine. https://doi.org/10.1056/nejm198507183130306
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
